Sterile Injectable Drugs Market Analysis

  • Report ID: 3050
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Sterile Injectable Drugs Market Analysis

The market is segmented by drug class into insulin, hormones, vaccines, peptide antibiotic, cytokines, and others, out of which, the vaccines segment is anticipated to hold the largest share in the market during the forecast period on account of escalating demand for vaccines for various infectious diseases, with respect to the spread of coronavirus, and other viral and bacterial diseases, including smallpox, measles, rubella, polio, and others. The insulin segment is also anticipated to witness major market share over the forecast period, owing to the rising cases of type 1 and type 2 diabetes. 

On the basis of distribution channel, the market is segmented into hospitals, pharmacy, ambulatory surgical centers, and others. Out of these, the hospitals segment is anticipated to witness highest CAGR over the forecast period on the back of higher patient pool, ease of availability, and greater credibility of hospitals over general pharmacies.

Our in-depth analysis of the global market includes the following segments:

           By Type

  • Small Molecule
  • Large Molecule

             By Drug Class

  • Insulin
  • Hormones
  • Vaccines
  • Peptide Antibiotics
  • Cytokines
  • Others

 

 

           By Application

  • Pain
  • Infections
  • Autoimmune Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Other

           By Distribution Channel

  • Hospitals
  • Pharmacy
  • Ambulatory Surgical Centers
  • Others
 

 

 

 

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3050
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising government initiatives to curb spread of chronic diseases is one of the major factors driving the market growth.

The market is anticipated to attain a considerable CAGR over the forecast period, i.e., 2021-2029.

Delay in drugs approval is one of the factors estimated to hamper the market growth.

The market in North America is estimated to garner the largest market share owing to the health awareness among people, high investment healthcare sector, and increasing R&D activities.

The major players in the market are GlaxoSmithKline plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Amgen Inc., Novartis AG, Progenity, Inc., Johnson & Johnson Services, Inc. and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample